Chungbuk National University Hospital

Cheongiu 28644

0 studies enrolling now · 3 studies all time

What they study most

Kidney Disease, Chronic, Lung Cancer, Non-squamous, Non-small Cell, Myocardial Infarction

Studies at this site

• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed